A Trend That Demands Attention
For most of medical history, colorectal cancer was considered a disease of older adults. Standard screening guidelines were built around that assumption, recommending colonoscopies beginning at age 50 for average-risk individuals. That assumption is now being challenged by data that should be taken seriously by anyone under 50.
Since the mid-1990s, incidence rates of colorectal cancer in adults under 50 have been rising by approximately 2% per year in the United States. The American Cancer Society updated its screening age recommendation to 45 in 2021 specifically in response to this trend. The National Cancer Institute's SEER database shows that while overall colorectal cancer rates have declined in older adults (thanks to increased screening), rates in younger adults continue to climb.
This matters because younger adults are not being screened. Symptoms are frequently dismissed as IBS, haemorrhoids, or anxiety. Diagnoses are delayed. And when colorectal cancer is diagnosed late, outcomes are significantly worse.
What Is Driving the Increase?
Researchers are actively investigating why younger adults are developing colorectal cancer at increasing rates. No single cause has been identified, but several factors have strong epidemiological associations.
Ultra-processed food consumption has increased dramatically across Western countries since the 1980s. Ultra-processed foods are associated with reduced microbiome diversity, chronic low-grade inflammation, and altered bowel transit — all factors linked to colorectal cancer development. A 2022 study in The BMJ found that consuming more than five servings of ultra-processed food daily was associated with a 29% increased risk of colorectal cancer in men.
Obesity and metabolic syndrome have risen in parallel with colorectal cancer rates in young adults. Visceral adiposity increases systemic inflammation and insulin-like growth factor (IGF-1) signalling, both of which promote colorectal cancer cell growth. The relationship is dose-dependent — higher BMI correlates with higher risk.
Sedentary behaviour is independently associated with colorectal cancer risk. Physical activity promotes gut motility (reducing contact time between potential carcinogens and the colonic mucosa), modulates insulin sensitivity, and reduces systemic inflammation.
Gut microbiome disruption is an emerging area of research. Early antibiotic exposure, caesarean birth, formula feeding, and low-fiber diets all alter the gut microbiome in ways that may affect colorectal cancer risk. Certain bacterial species — particularly Fusobacterium nucleatum — are consistently found in higher concentrations in colorectal tumours and may have a direct role in cancer progression.
Alcohol consumption is a well-established risk factor. Ethanol is converted to acetaldehyde in the gut, which damages DNA and impairs DNA repair mechanisms. Even moderate regular drinking (1–2 drinks per day) is associated with increased colorectal cancer risk.
Symptoms That Should Not Be Ignored
One of the most dangerous aspects of colorectal cancer in young adults is the tendency to attribute symptoms to less serious conditions. Doctors themselves are more likely to investigate symptoms of concern in older patients, sometimes delaying diagnosis in younger patients by months or years.
Symptoms that warrant prompt medical investigation include persistent changes in bowel habits (diarrhoea, constipation, or alternating between the two) lasting more than two to three weeks; any blood in the stool or on toilet paper (more than a single episode); rectal pain or a persistent feeling of incomplete evacuation; unexplained abdominal cramping or pain; unexplained weight loss; and persistent fatigue, particularly when combined with other symptoms.
None of these symptoms are specific to colorectal cancer — each can have benign explanations. But each also warrants investigation, particularly when persistent, when combined with other symptoms, or when accompanied by a family history of colorectal cancer.
Screening Options Available Today
The colonoscopy remains the gold standard for colorectal cancer screening — it can both detect and remove precancerous polyps in a single procedure. However, it requires bowel preparation, sedation, and time off work, which creates significant barriers to uptake, particularly among younger adults.
Non-invasive screening alternatives are available and effective. The faecal immunochemical test (FIT) detects blood in stool and should be performed annually. Cologuard is an FDA-approved stool DNA test that detects both blood and abnormal DNA shed from colorectal cells, performed every three years. Both are substantially more accessible than colonoscopy and are covered by Medicare and many private insurance plans for adults 45 and older.
For younger adults with symptoms, family history, or other risk factors, it is appropriate to discuss screening with a primary care physician regardless of age.
What You Can Do
The evidence supports several lifestyle modifications that reduce colorectal cancer risk: increasing dietary fiber intake (particularly from whole grains, legumes, and vegetables); reducing consumption of processed and red meats; maintaining a healthy weight; engaging in regular physical activity; limiting alcohol consumption; and not smoking.
These are the same lifestyle factors that support overall gut health. None of them are novel, but the context matters: eating more fiber, moving more, and drinking less alcohol is not merely about feeling better. There is robust evidence that these behaviours meaningfully reduce colorectal cancer risk.
And if you are 45 or older, or younger with risk factors or symptoms — please speak to your doctor about screening. The conversation is more important than any embarrassment.